Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection

M. Snee; Lucy McParland; Fiona Jane Collinson; Alina Striha; David Baldwin; Babu V Naidu; David Sebag‐Montefiore; Walter Martin Gregory; Janine Bestall; Jenny Hewison; Samantha Hinsley

doi:10.1186/s40814-016-0095-6

Enriched recordOpen access

Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection

M. Snee, Lucy McParland, Fiona Jane Collinson, Alina Striha, David Baldwin, Babu V Naidu, David Sebag‐Montefiore, Walter Martin Gregory, Janine Bestall, Jenny Hewison, Samantha Hinsley

Pilot and Feasibility Studies2016doi:10.1186/s40814-016-0095-6

Citation graph

Read manuscript

Open PDF in a new tab

Open the manuscript using the link above. DOC files open in Word or a compatible document reader.

Abstract

[This corrects the article DOI: 10.1186/s40814-016-0046-2.].

Open public full text

Rights: ALLOWED · cc-by · Source: journal-auto-sync:external:CROSSREF_ISSN

Read manuscript

Open PDF in a new tab

Open the manuscript using the link above. DOC files open in Word or a compatible document reader.

Authors

M. Snee#1 Lucy McParland#2 Fiona Jane Collinson#3 Alina Striha#5 David Baldwin#6 Babu V Naidu#7 David Sebag‐Montefiore#8 Walter Martin Gregory#9 Janine Bestall#10 Jenny Hewison

Referenced works

View all references →

The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection

2016 · 44 citations

Cited by

View all cited-by records →

No local citing links have been materialized yet.

Read manuscript

Open PDF in a new tab

Open the manuscript using the link above. DOC files open in Word or a compatible document reader.

External reference records

10.1186/s40814-016-0046-2

10.1186/s40814-016-0046-2 · 2016

Additional external references

No additional external references are available.